Nationwide Children's Becomes Qualified Treatment Center for Glycogen Storage Disease Type 1A Gene Therapy
August 21, 2026
August 21, 2026
COLUMBUS, Ohio, Aug. 21 [Category: BizHealth Care] -- Nationwide Children's Hospital posted the following news release:
* * *
Nationwide Children's Becomes Qualified Treatment Center for Glycogen Storage Disease Type 1A Gene Therapy
*
(COLUMBUS, Ohio) - Nationwide Children's has been designated a qualified treatment center for GENGLYCOS(tm) (pariglasgene brecaparvovec-opnr), a gene therapy for the treatment of glycogen storage di . . .
* * *
Nationwide Children's Becomes Qualified Treatment Center for Glycogen Storage Disease Type 1A Gene Therapy
*
(COLUMBUS, Ohio) - Nationwide Children's has been designated a qualified treatment center for GENGLYCOS(tm) (pariglasgene brecaparvovec-opnr), a gene therapy for the treatment of glycogen storage di . . .